Phase 1 Study of TG02 Citrate in Patients With Advanced Hematological Malignancies

NCT01204164 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

AML
ALL
Blast Crisis
MDS
Multiple Myeloma

Interventions

DRUG: TG02 citrate
DRUG: Carfilzomib
DRUG: Dexamethasone

Sponsor

Tragara Pharmaceuticals, Inc.